Regenerative Medicine
| Product Code | GIA00233 |
| Publication Date | October 2010 |
| Publisher | Global Industry Analysts |
| Product Type | Report |
| Pages | 381 |
| ISBN Number | not applicable |
Regenerative Medicine
This report analyzes the worldwide markets for Regenerative Medicine in US$ Million.The report provides separate comprehensive analytics for the US, Japan, and Europe. Annual estimates and forecasts are provided for the period 2009 through 2015. A six-year historic analysis is also provided for these markets. The report profiles 106 companies including many key and niche players such as BioVest International, Inc., Curis, Inc., Cytori Therapeutics, Inc., DeveloGen AG, Forticell Bioscience, Inc., Geron Corporation, Integra Orthobiologics, LifeCell Corporation, Osiris Therapeutics, Inc., Tengion, Tepha Inc., and TiGenix N.V.
Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Contents
- 1.Introduction, Methodology & Product Definitions
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
- 2.Industry Overview
- Market Potential
- Regenerative Medicine in Bone and Joint Applications
- US Corners A Lion's Share
- Regenerative Medicine - The past, The Present, & The Future
- Another Revolution in The Making?
- Conventional Chemical Medicine vs Regenerative Medicine
- The Need for Regenerative Medicine
- Regenerative Medicine Throws in Several New Therapies
- What's in Store?
- Regenerative Medicine to Arrest Ageing
- Thriving on An Aging World Population
- Faster Healing Process
- Regenerative Medicine to Overcome Donor Organs Shortage
- Possible Scenarios
- Stem Cell Research – Not Just Another Medical Advancement
- Key Issues at Play
- Growth Drivers
- Trends & Issues
- Biomaterials Sought after in Regenerative Medicine
- Upbeat Market for Cell-Based Tissue Engineering
- Progenitor Cell Therapy to Witness No Holds Barred Growth
- Players Embrace Automation in Production Facilities
- Contract Manufacturing, A Growing Sector
- Investors Wary of Funding Regenerative Medicine
- Regenerative Medicine Field Lags behind Due to Segregated Focus
- Challenges to Be Encountered by Tissue Engineering Companies
- Activity in The Field of Regenerative Medicine
- 3.Product Overview
- Regenerative Medicine Advances in Four Phases
- Human Substances
- Tissue Engineering
- Therapeutic Cloning
- Nanotechnology-Driven Biomaterials
- Types of Regenerative Medicine
- Type I – Regenerative Medicine
- Human Proteins and Genes Are Drugs in Regenerative Medicine
- Type-2 Regenerative Medicine
- Therapies Based on Human Cells and Tissues
- Type-3 Regenerative Medicine
- Based on Embryonic Stem Cells
- The Opponents of The Esc Theory
- Embryonic Stem Cells – Shortcomings
- Type-4 Regenerative Medicine
- Based on Novel Materials / Material Science Advancements
- Overview of Major Regenerative Medicine Techniques
- Natural Regenerative Proteins
- Tissue Engineering Capable of Culturing Replacement Organs
- All about Stem Cells
- Adult Stem Cells
- Adult Stem Cell Research Eludes Ethical Dispute
- Hesc – Highly Capable of Differentiating and Multiplying
- Stem Cell Research in Development of Regenerative Medicine
- Neural Stem Cell to Restore Memory Functioning
- Pancreatic Islet Cells to Control Blood Sugar in Diabetics
- Therapeutic Cloning to Cure Parkinson's
- 4.Regulatory Environment
- Regulatory Norms Governing Es Cell Research
- Milestones in The Human Embryonic Stem Cell Research: 2001
- Legality of Es Cell Use in Major Developed Nations
- 5.Technological Innovations / Breakthroughs
- Kensey Nash's Medeor Ecm Receives Approval from US Fda
- Celling Technologies Unveils Res-Q Device
- Kinetic Wins Fda Approval for Lifecell Tissue Matrix
- 6.Technological Innovations in Recent past – A Perspective Builder
- Celprogen Launches 11 Cancer Stem Cells
- Biovest International Launches Autovaxid™
- Stelic Institute Announces New Treatment Method for Acute Liver Failure
- Tissuegene Initiates Phase 1 Clinical Trials for Tg-C
- Isto Announces Fda's Ind Approval for Neocartilage Graft
- Cook Biotech Introduces Surgisis® Afp™ Anal Fistula Plug
- Korean Scientists Make A Major Breakthrough in Stem Cell Lines
- Japanese Researchers Regenerate Jaw Bone
- Geron Researchers Differentiate Hepatocytes from Hescs
- Geron Demonstrates Potential of Hescs in Treatment of Parkinson's Disease
- Geron Researches Cardiomyocytes for Heart Disease
- Endovasc Announces New Findings at Texas Heart Institute Research
- Geron and Celera Genomics Complete Characterization of Active Genes in Hescs
- Rockefeller University Develops Solution for Maintaining Plupotency in Hescs
- 7.Recent Industry Activity
- Power3 Medical Inks Definitive Agreement to Acquire Stemtronix
- Healthpoint Acquires Cyzacttm and Icx-Skn Technologies from Intercytex
- Stem Cell Therapy International Merges with Histostem
- Tigenix Acquires Orthomimetics
- Integra Inks Licensing Deal with Organogenesis
- Depuy Spine Collaborates with Atrm
- Epistem Enters into Partnership with Novartis
- Athersys Inks Agreement with Pfizer
- Beike Biotechnology Signs Investment Agreement with Biomaster
- Fujifilm Establishes New Drug Discovery Labs
- Kci Acquires Lifecell
- Organogenesis Takes over Nanomatrix
- Cytori and Green Hospital Supply Ink Strategic Equity Deal
- Sigma-Aldrich Signs Agreement with Alphagenix
- Rnl Bio Establishes Research Unit at Newcastle University
- Pfizer Establishes New Regenerative Medicine Research Unit
- Tengion Begins Third Phase Ii Clinical Trial of Neo-Bladder Augment™
- 8.Corporate Activity in Recent past – A Perspective Builder
- Integra Life Sciences Acquires Isotis, Inc.
- Geron Increases Stake in Ta Therapeutics
- Organogenesis Signs Mou with Ntec
- Biotime Establishes New Stem Cell Division
- Novathera and Gamida Join Hands for Developing Cell Therapeutics for Lung Regeneration
- Tigenix Teams up with Fidea to Develop Biological Joint Implants
- Scotland Plans to Build Center for Regenerative Medicine in Edinburgh
- 9.Focus on Select Global Players
- Biovest International, Inc. (US)
- Curis, Inc. (US)
- Cytori Therapeutics, Inc. (US)
- Develogen Ag (Germany)
- Forticell Bioscience, Inc. (US)
- Geron Corporation (US)
- Integra Orthobiologics (US)
- Lifecell Corporation (US)
- Osiris Therapeutics, Inc. (US)
- Tengion (US)
- Tepha Inc. (US)
- Tigenix N.V. (Belgium)
- 10.Global Market Perspective
- Table 1: World Recent past, Current & Future Market Analysis for Regenerative Medicine Products for Bone and Joint Applications by Geographic Region – US, Japan and Europe Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2015 (Includes Corresponding Graph/Chart)
- Table 2: World Historic Review for Regenerative Medicine Products for Bone and Joint Applications by Geographic Region – US, Japan, and Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (Includes Corresponding Graph/Chart)
- Table 3: World 11-Year Perspective for Regenerative Medicine Products for Bone and Joint Applications by Geographic Region – Percentage Breakdown of Dollar Sales for US, Japan and Europe for Years 2005, 2010 & 2015 (Includes Corresponding Graph/Chart)
- 11.The United States
- A. Market Analysis
- Market Potential
- Regenerative Medicine in Bone and Joint Applications
- Table 4: US Market for Regenerative Medicine Products for Bone and Joint Applications (2007, 2010 & 2013): Percentage Breakdown of Value Sales for Bone Replacement Grafting, Bone Growth Stimulators, and Tissue Engineering Cartilage (Includes Corresponding Graph/Chart)
- Regenerative Therapy – Best Fit for Joint Problems
- Millions of American Patients Put Their Hope in Stem Cell Research
- Table 5: Prevalence of Various Diseases in The US (Includes Corresponding Graph/Chart)
- US Witnesses Mixed Response for Government Support for Hesc Research
- Cbi's Human Tissue Products for Treating Liver Failure and Diabetes
- Market for Liver and Pancreas Transplantation
- Implantable Regenerative Products Take over Sports Medicine
- Key Players
- Other Dominating Regional Players
- B. Market Analytics
- Table 6: US Recent past, Current & Future Analysis for Regenerative Medicine Products for Bone and Joint Applications – Annual Sales Figures in US$ Million for Years 2009 through 2015 (Includes Corresponding Graph/Chart)
- Table 7: US Historic Review for Regenerative Medicine Products for Bone and Joint Applications Market with Annual Sales Figures in US$ Million for Years 2003 through 2008 (Includes Corresponding Graph/Chart)
- 12.Japan
- A. Market Analysis
- Market Potential
- Research Activity in Regenerative Medicine Field
- More Companies Eye The Regenerative Medicine Potential
- Competition Heats up behind Closed Doors
- Japanese Firms Need to Catch up with US and European Competitors
- Science Ministry Rolls out Regenerative Medicine Project
- Regenerative Medicine Exempted from Ban on Human Cloning
- B. Market Analytics
- Table 8: Japanese Recent past, Current & Future Analysis for Regenerative Medicine Products for Bone and Joint Applications with Annual Sales Figures in US$ Million for Years 2009 through 2015 (Includes Corresponding Graph/Chart)
- Table 9: Japanese Historic Review for Regenerative Medicine Products for Bone and Joint Applications with Annual Sales Figures in US$ Million for Years 2003 through 2008 (Includes Corresponding Graph/Chart)
- 13.Europe
- A. Market Analysis
- Oral Tissue Regeneration
- Table 10: European Oral Tissue Regeneration Market (2009): Percentage Breakdown of Value Sales for Bone Graft Material, Membranes, and Tissue Regeneration (Includes Corresponding Graph/Chart)
- Regional Overview
- Germany
- Key Players
- United Kingdom
- Belgium
- Select Player
- B. Market Analytics
- Table 11: European Recent past, Current & Future Analysis for Regenerative Medicine Products for Bone and Joint Applications with Annual Sales Figures in US$ Million for Years 2009 through 2015 (Includes Corresponding Graph/Chart)
- Table 12: European Historic Review for Regenerative Medicine Products for Bone and Joint Applications Market with Annual Sales Figures in US$ Million for Years 2003 through 2008 (Includes Corresponding Graph/Chart)
- 14.Review of Regenerative Medicine in Other Geographic Markets
- 14a.Canada
- University of Toronto – Spearheading Regenerative Medicine Research
- 14b.Asia-Pacific
- China
- Substantial Government Support
- India
- Csir- Leading The Way in Regenerative Medicine Research
- High Growth Opportunities
- Australia
- Key Player
- Stem Cell Sciences
- South Korea
- Malaysia
- Singapore
- 14c.Rest of World
- Argentina
- Israel
- Select Major Players
- Colbar R&d Ltd.
- Prochon Biotech Ltd.
- South Africa
- Competition
- Total Companies Profiled: 106 (Including Divisions/Subsidiaries - 111)
- Region/Country/Players
- The United States
- Canada
- Japan
- Europe
- Germany
- The United Kingdom
- Italy
- Rest of Europe
- Asia-Pacific (Excluding Japan)
- Latin America
- Africa
- Middle-East